1. Home
  2. HSAI vs IRON Comparison

HSAI vs IRON Comparison

Compare HSAI & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hesai Group each ADS represents one Class B ordinary share

HSAI

Hesai Group each ADS represents one Class B ordinary share

HOLD

Current Price

$16.66

Market Cap

2.7B

Sector

N/A

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$69.56

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HSAI
IRON
Founded
2014
2017
Country
China
United States
Employees
733
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.6B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
HSAI
IRON
Price
$16.66
$69.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
11
Target Price
$31.58
$103.18
AVG Volume (30 Days)
1.7M
372.0K
Earning Date
05-19-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$46.29
N/A
Revenue Next Year
$41.32
$283.52
P/E Ratio
$61.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.69
$40.00
52 Week High
$30.85
$99.50

Technical Indicators

Market Signals
Indicator
HSAI
IRON
Relative Strength Index (RSI) 35.43 52.90
Support Level $14.69 $64.48
Resistance Level $24.05 $71.85
Average True Range (ATR) 0.93 3.26
MACD -0.22 0.11
Stochastic Oscillator 1.48 60.38

Price Performance

Historical Comparison
HSAI
IRON

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: